证券日报网讯1月16日，国海证券在互动平台回答投资者提问时表示，截至2025年12月31日股东户数为 183147户。 ...

Core Viewpoint - The transformation of wealth management has become an industry consensus, with a shift from traditional brokerage and distribution services to differentiated services, primarily through the establishment and development of a buy-side advisory model [3][7]. Group 1: Buy-Side Advisory Model - The buy-side advisory model represents a fundamental change in the business model, distinguishing itself from the sell-side model, which charges product issuers, by directly providing professional services to clients and charging them accordingly [3][7]. - The buy-side advisory model is seen as a key direction for companies to create differentiated advantages in the wealth management industry [3][7]. Group 2: Rationale for Buy-Side Advisory - The buy-side advisory model addresses client pain points, focusing on providing tailored solutions that meet clients' actual needs rather than merely selling products [4][8]. - The long-term commercial value of the buy-side advisory model is significant, as traditional channel businesses are experiencing a decline, with recent trading volumes reaching over 30 trillion, reflecting a 3-4 times increase compared to the previous year, yet retail brokerage revenues have not grown at the same pace [4][9]. - The current financial asset ownership among the Chinese public is only 15%, comparable to the state of the U.S. market 20-30 years ago, indicating substantial future growth potential for wealth management services [4][9]. Group 3: Industry and Client Demand - There is a mutual drive between industry transformation and increasing client demand for professional advisory services, as market rules become more complex [5][9]. - The commitment to developing the buy-side advisory model aligns with deep client needs and presents significant commercial value and strategic opportunities for the wealth management industry [5][9].

Group 1 - The core viewpoint emphasizes the need for the wealth management industry to break free from a reliance on market conditions, focusing instead on genuinely accompanying clients through market cycles [1][3] - Institutions must undergo a fundamental shift in their business model, prioritizing customer-centric approaches through deep service, expectation management, and behavioral guidance to achieve long-term client satisfaction [1][3] - Traditional methods of simply recommending stocks or sectors without understanding clients' investment goals and risk preferences are deemed irresponsible, highlighting the importance of consistent service logic regardless of market conditions [3] Group 2 - The process of client service should begin with comprehensive account diagnostics and KYC (Know Your Customer), leading to customized long-term solutions based on individual client needs [3] - Client satisfaction is defined as meeting expectations, where managing client expectations is crucial; high returns alone do not guarantee satisfaction [3] - Education and ongoing support are essential, requiring long-term communication to guide clients in establishing realistic expectations within the service capabilities [3][4] Group 3 - The discussion includes the perspective that AI is unlikely to fully replace human investment advisors, as the personal touch in one-on-one client education and support remains vital [4]

Group 1 - The core viewpoint of the forum emphasizes the need for the wealth management industry to break free from reliance on market conditions and focus on genuinely accompanying clients through market cycles [1][3] - Institutions must fundamentally transform their business models to be client-centric, providing deep services, managing expectations, and guiding behaviors to achieve long-term client satisfaction [1][3] - Traditional methods of simply recommending stocks or sectors without understanding clients' investment goals and risk preferences are deemed irresponsible [3] Group 2 - The process of client service should begin with comprehensive account diagnostics and KYC (Know Your Customer), leading to customized long-term solutions based on individual client needs [3] - Client satisfaction is defined as meeting expectations, and managing these expectations is crucial for maintaining satisfaction levels [3] - Even with high-quality investment advice, client behavior can still impact outcomes, necessitating the role of advisors as "behavior coaches" to help clients make rational investment decisions [3]

每经AI快讯，恒锋信息发布公告称，2026年1月13日10：00-11：00，恒锋信息接受国海证券等投资者调 研，公司副总裁、董事会秘书陈凡，证券事务代表林真铃参与接待，并回答了投资者提出的问题。 （记者 曾健辉） 每经头条（nbdtoutiao）——不到20万元，就能买特斯拉了？"廉价版"Model 3或进入中国市场，续航里 程480公里！关于自动驾驶，美国市场也有大调整 ...

Core Viewpoint - Guohai Securities initiates coverage on Zhonghui Biological-B (02627) with a "Buy" rating, predicting the company will achieve profitability by 2027, leading to a dual boost in performance and valuation known as the "Davis Double Play" [1] Group 1: Company Overview - Zhonghui Biological focuses on innovative vaccine upgrades and has entered the commercialization phase [1] - The company was established in 2015 and is dedicated to the research, manufacturing, and commercialization of innovative vaccines and traditional vaccines using new technologies [1] Group 2: Product Pipeline - The company's core product, Huiliankangxin (Quadrivalent Influenza Virus Subunit Vaccine), has been launched and is expected to generate revenue of 260 million yuan in 2024, a 398% increase year-on-year [2] - The 23-valent pneumococcal polysaccharide vaccine and freeze-dried human rabies vaccine (human diploid cells) have completed Phase I clinical trials [1] Group 3: Market Potential - The domestic influenza vaccine market has significant growth potential, with split vaccines currently dominating market share [2] - The rabies vaccine market is substantial, with approximately 18 to 20 million people in China receiving rabies vaccinations annually [3] Group 4: Technological Advancements - The company has developed a leading core technology platform that supports both traditional vaccine upgrades and innovative vaccine development, with a pipeline of 11 vaccines under research [4] - The in-development human diploid cell rabies vaccine has shown good safety in Phase I trials and is designed for convenient administration [3]

中慧生物专注创新疫苗升级，已进入商业化兑现期 公司成立于2015年，致力于创新疫苗及采用新技术方法的传统疫苗的研发、制造及商业化。目前公司四 价流感病毒亚单位疫苗(6月龄及以上)已上市销售。23价肺炎球菌多糖疫苗、冻干人用狂犬病疫苗(人二 倍体细胞)已完成Ⅰ期临床试验。 国海证券发布研报称，首次覆盖，给予中慧生物-B(02627)"增持"评级，预测公司有望在2027年实现盈 利，迎来业绩与估值双重提升的"戴维斯双击"。考虑到公司核心产品慧尔康欣持续放量，预计2025- 2027年公司实现营业收入4.93、7.98、12.40亿元人民币，公司疫苗管线丰富，发展后劲充足。 狂犬病高度危险，国内暴露者人数呈上升趋势，近几年国内每年约1800万至2000万人接种狂犬疫苗。在 狂犬病疫苗生产技术中，人二倍体细胞是WHO推荐的最安全基质之一，目前市面仅2种该细胞株的狂犬 疫苗。公司的在研人二倍体细胞狂犬病毒疫苗，Ⅰ期临床试验显示出良好的安全性，同时结合冻干制剂 及预灌封稀释剂注射器，并开发多种接种方案，接种更加便捷灵活。2025年12月其Ⅲ期临床试验已启 动。 国海证券主要观点如下： 慧尔康欣(四价流感病毒亚单位疫苗)： ...

每经AI快讯，利欧股份发布公告称，2026年1月14日，利欧股份接受国海证券等投资者调研，公司董 事、副总经理、董事会秘书张旭波，副总经理郑晓东参与接待，并回答了投资者提出的问题。 每经头条（nbdtoutiao）——海利生物增值9倍并购的企业，估值8个月"腰斩"，其第一大客户竟是尚未 成立的公司，离奇的事还不少…… （记者 曾健辉） ...

《投资时报》作为深度垂直于上市公司、金融机构两大领域的专业化全国性财经类媒体，凭借原创内容和深度报道的多年积累打造了行业的影响力和 权威性。 国海证券始终秉承专业专注、全心全力的服务理念，追求高质量发展。2025年服务实体经济投融资额明显提升，实现功能性和效益性的协同共进；公 司治理效能稳步提升，躬身践行中国特色金融文化；特色化差异化发展路径更加清晰，研究、财富管理、资产管理等业务量质双升；服务广西更深更 实，紧扣"北上广研发+广西集成+东盟应用"人工智能发展路径，为"科创桂林"、柳州"人工智能+制造"等提供精准专业服务；市场认可度和品牌美誉度 显著增强，斩获"最具潜力研究机构""最具特色财富管理品牌""股权投资机构金牛奖"等行业重要奖项。 创新是证券公司差异化发展的关键之匙。2025年，国海证券成功发行广西首单"一带一路"永续公司债、广西首单数字人民币公司债券等首单项目，启 动"人工智能+"三年行动，荣获自治区2025人工智能赋能金融创新大赛三等奖等奖项，成立东盟研究院/广西发展研究中心，深入打造"立足广西、覆盖 全国、辐射东盟"券商智库品牌，多个创新在各业务线已开花结果。 国海证券资管始终以"追求可持续的 ...

证券日报网讯1月12日，国海证券在互动平台回答投资者提问时表示，公司截至2025年12月19日的股东 户数为184305户。 ...